CAMINITI, Giuseppe
CAMINITI, Giuseppe
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.006 secondi).
Evaluation of SARS-CoV-2 genomic mutations potentially conferring resistance to antiviral drugs in viral populations isolated from untreated SARS-CoV-2-infected subjects.
2023-02-15 Caminiti, Giuseppe
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy
2020-01-01 Lombardo, D.; Saitta, C.; Giosa, D.; Di Tocco, F. C.; Musolino, C.; Caminiti, G.; Chines, V.; Franze, M. S.; Alibrandi, A.; Navarra, G.; Raimondo, G.; Pollicino, T.
HBV-integration studies in the clinic: Role in the natural history of infection
2021-01-01 Pollicino, T.; Caminiti, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Evaluation of SARS-CoV-2 genomic mutations potentially conferring resistance to antiviral drugs in viral populations isolated from untreated SARS-CoV-2-infected subjects. | 15-feb-2023 | Caminiti, Giuseppe | |
| Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy | 1-gen-2020 | Lombardo, D.; Saitta, C.; Giosa, D.; Di Tocco, F. C.; Musolino, C.; Caminiti, G.; Chines, V.; Franze, M. S.; Alibrandi, A.; Navarra, G.; Raimondo, G.; Pollicino, T. | |
| HBV-integration studies in the clinic: Role in the natural history of infection | 1-gen-2021 | Pollicino, T.; Caminiti, G. |